Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patients

Jasmine A. McQuerry, Merry Mclaird, Samantha N. Hartin, John C. Means, Jeffrey Johnston, Tomi Pastinen, Scott T. Younger
doi: https://doi.org/10.1101/2021.11.02.21265771
Jasmine A. McQuerry
1Genomic Medicine Center, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
2Children’s Mercy Research Institute, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Merry Mclaird
1Genomic Medicine Center, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
2Children’s Mercy Research Institute, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha N. Hartin
1Genomic Medicine Center, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
2Children’s Mercy Research Institute, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Means
1Genomic Medicine Center, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
2Children’s Mercy Research Institute, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Johnston
1Genomic Medicine Center, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
2Children’s Mercy Research Institute, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomi Pastinen
1Genomic Medicine Center, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
2Children’s Mercy Research Institute, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
3Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64110, USA
4Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott T. Younger
1Genomic Medicine Center, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
2Children’s Mercy Research Institute, Children’s Mercy Kansas City, Kansas City, MO 64108, USA
3Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64110, USA
5Department of Pediatrics, University of Kansas Medical Center, Kansas City, KS 66160, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: styounger@cmh.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Clinical whole genome sequencing has enabled the discovery of potentially pathogenic noncoding variants in the genomes of rare disease patients with a prior history of negative genetic testing. However, interpreting the functional consequences of noncoding variants and distinguishing those that contribute to disease etiology remains a challenge. Here we address this challenge by experimentally profiling the functional consequences of rare noncoding variants detected in a cohort of undiagnosed rare disease patients at scale using a massively parallel reporter assay. We demonstrate that this approach successfully identifies rare noncoding variants that alter the regulatory capacity of genomic sequences. In addition, we describe an integrative analysis that utilizes genomic features alongside patient clinical data to further prioritize candidate variants with an increased likelihood of pathogenicity. This work represents an important step towards establishing a framework for the functional interpretation of clinically detected noncoding variants.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by generous philanthropic contributions to the Children's Mercy Research Institute and the Genomic Answers for Kids program.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Institutional Review Board (IRB) of Children's Mercy Research Institute gave ethical approval for this work (Study #11120514).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The Gene Expression Omnibus accession number for the MPRA and bulk RNA sequencing data described in this paper is GSE185795. The dbGaP accession number for whole genome sequencing data described in the paper is phs002206.v2.p1.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 04, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patients
Jasmine A. McQuerry, Merry Mclaird, Samantha N. Hartin, John C. Means, Jeffrey Johnston, Tomi Pastinen, Scott T. Younger
medRxiv 2021.11.02.21265771; doi: https://doi.org/10.1101/2021.11.02.21265771
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Massively parallel identification of functionally consequential noncoding genetic variants in undiagnosed rare disease patients
Jasmine A. McQuerry, Merry Mclaird, Samantha N. Hartin, John C. Means, Jeffrey Johnston, Tomi Pastinen, Scott T. Younger
medRxiv 2021.11.02.21265771; doi: https://doi.org/10.1101/2021.11.02.21265771

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (422)
  • Epidemiology (8996)
  • Forensic Medicine (4)
  • Gastroenterology (420)
  • Genetic and Genomic Medicine (1960)
  • Geriatric Medicine (191)
  • Health Economics (403)
  • Health Informatics (1330)
  • Health Policy (661)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10817)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1834)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1000)
  • Ophthalmology (298)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (581)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1906)
  • Public and Global Health (4125)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (368)
  • Respiratory Medicine (550)
  • Rheumatology (225)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)